GlassScriptPhysician profile
Matthew James Johnson
NPI 1891150777
$6,891.95
in general payments reported to CMS, 2019-2025
14 companies · $531 in 2025
The $531 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $770 · 2020: $527 · 2021: $278 · 2022: $4,085 · 2023: $282 · 2024: $419 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,210 · Travel and Lodging: $22.43.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,210.10 |
| Travel and Lodging | $22.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $3,249.92 | 2019-2022 | |
| Arthrex, INC. | $1,567.68 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $921.48 | 2019-2023 | |
| Integra Lifesciences Corporation | $174.09 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $172.45 | 2021-2024 | Evos |
| Polynovo North America LLC | $161.70 | 2025 | Novosorb Btm |
| Paragon 28, INC. | $145.28 | 2021 | |
| Averitas Pharma INC. | $140.14 | 2025 | Qutenza |
| Trimed, INC. | $103.22 | 2025 | |
| Flower Orthopedics Coporation | $86.21 | 2024 | |
| Convatec INC. | $84.70 | 2025 | |
| Kerecis Limited | $46.61 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Graftguide |
| Biocomposites INC | $22.42 | 2025 | Stimulan |
| Bioventus LLC | $16.05 | 2023 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.